Payer PolicyActive
SURG.00113 Artificial Retinal Devices
ANTHEM-SURG.00113
Anthem
Effective: April 16, 2025
Updated: December 30, 2025
Policy Summary
This policy addresses artificial retinal devices, including epiretinal and subretinal retinal implant systems intended to restore vision in retinal diseases (e.g., retinitis pigmentosa, AMD). Anthem considers these devices investigational and not medically necessary; they are not covered for any indication. This noncoverage applies to all models/uses, including services billed under C1841, C1842, and L8608.
Coverage Criteria Preview
Key requirements from the full policy
"The use of artificial retinal devices is consideredinvestigational and not medically necessaryfor all indications."
Sign up to see full coverage criteria, indications, and limitations.